Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
glioblastoma
Biotech
TME's hunt for partner for brain cancer nears conclusion
TME’s hunt for a partner for its brain cancer drug is close to bearing fruit as the biotech clings to its hope of generating $1 billion in sales.
James Waldron
Aug 24, 2026 10:13am
Evaxion scraps tumor vaccine to focus on brain cancer candidate
Aug 17, 2026 9:18am
Novocure device fails to improve brain cancer patients’ survival
Jun 18, 2026 8:25am
CNS Pharma wipes glioblastoma pipeline clean in strategic pivot
Mar 11, 2026 10:30am
Potential brain tumor pill shrinks tumors in mice
Jan 28, 2026 2:00pm
Cash-strapped TME rethinks eye drug plan after losing partner
Jan 5, 2026 6:50am
